Search the Newsreel

Mangalam Cement Standalone June 2026 Net Sales at Rs 455.22 crore, up 0.77% Y-o-Y

Alamar Biosciences (ALMR) Earnings Date and Reports 2026

Lambodhara Textiles Ltd is Rated Sell

Alamar outlines $116M-$120M 2026 revenue outlook while targeting 100+ instruments and $400,000+ pull-through

Earnings Call Insights: Alamar Biosciences (ALMR) Q2 2026 MANAGEMENT VIEW * “Q2 2026 was a strong quarter that reflects the momentum of our business,” said Co-Founder, Chairman & CEO Yuling Luo, highlighting that “Total revenue grew 82% year-over-year,” that “Consumable revenue accounted for 53% …

Alamar Biosciences FY26 sales guidance beats estimates

Alamar Biosciences (NASDAQ: ALMR) reported strong Q2 2026 results with an 82% revenue surge to $29.4 million, primarily driven by a 147% increase in consumable sales. The company raised its full-year 2026 revenue guidance to $116-$120 million, surpassing analyst estimates. Despite a widening net …

Lam Research (NASDAQ:LRCX) Trading Down 1.6% - Should You Sell?

Lam Research (NASDAQ:LRCX) shares fell 1.6% on Monday, trading at around $306.40 with lower-than-average volume. Despite this, Wall Street analysts maintain a "Moderate Buy" consensus rating and a $358.47 average price target. The company recently exceeded quarterly earnings expectations, but insider selling totaling over …

Alamar Biosciences expands proteomics partnership by 86,000 samples

Alamar Biosciences is expanding its partnership with the Alzheimer’s Disease Data Initiative and Gates Ventures to analyze an additional 86,000 plasma samples using its NULISAseq Neuro 220 panel. This expansion builds on a previous initiative that profiled over 55,000 samples, aiming for a total …

Alamar: Q2 Earnings Snapshot

Alamar Biosciences Inc. (ALMR) reported a Q2 loss of $13.2 million, or 22 cents per share, which surpassed Wall Street expectations of a 36-cent loss. The biotech company, specializing in proteomics, posted revenue of $29.4 million for the period and projects full-year revenue between …

BEYAZ FILO OTO K - KAP Haberleri - 2026-08-10 tarihli

Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance

Alamar Biosciences reported strong second-quarter 2026 financial results, with total revenue increasing by 82% to $29.4 million and consumable revenue growing by nearly 150% year-over-year. The company also launched new products, including a multiplexed immunoassay for eMTBR-tau and the NULISAseq™ Immune 340 Panel, and …

Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures

Alamar Biosciences has expanded its partnership with the Alzheimer’s Disease Data Initiative and Gates Ventures to profile an additional 86,000 plasma samples using its NULISAseq™ Neuro 220 panel. This collaboration aims to create the largest neurodegenerative disease dataset, encompassing over 140,000 samples by 2027, …

Lam Research Corp. stock outperforms competitors despite losses on the day

Lam Research Corp. (LRCX) shares fell by 1.59% to $306.40 on Monday, underperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also experienced declines. Despite the daily loss, the article title suggests it outperformed competitors, though specific competitor data …

Lam Research (LRCX) Upgraded to Strong Buy: Here's Why

Investors might want to bet on Lam Research (LRCX), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The …

$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today

Alnylam Pharmaceuticals (NASDAQ: ALNY) has shown significant outperformance over the past two decades, with an annualized return of 15.23%. An initial investment of $1000 in ALNY stock 20 years ago would now be valued at $17,192.61. This highlights the substantial impact of compounded returns …

NASDAQ-100 PROFUND's Lam Research Corp(LRCX) Holding History

This article details NASDAQ-100 PROFUND's historical holdings in Lam Research Corp (LRCX) as of April 30, 2026. The fund holds 3,918 shares valued at $1.01 million, representing 1.57% of its portfolio. NASDAQ-100 PROFUND has made multiple purchases and sales of LRCX since 2021Q4, resulting …

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 71% Potential Upside Amid Strong Revenue Growth

Renaissance Technologies LLC Purchases 14,000 Shares of Alamo Group, Inc. $ALG

Renaissance Technologies LLC significantly increased its stake in Alamo Group, Inc. (NYSE:ALG) during the first quarter, adding 14,000 shares to bring its total holding to 16,400 shares, valued at approximately $2.7 million. The company reported strong quarterly earnings, surpassing analyst expectations with $2.82 in …

GREENLAM: Q1 FY27 revenue rose 18% YoY, chipboard turned EBITDA positive, and export delays shifted INR 27 crore to Q2

Earnings call transcript: Greenlam Industries Q1 2027 misses estimates, shares fall

GREENLAM: Q1 FY27 revenue rose 18% YoY, EBITDA surged, and chipboard turned EBITDA positive

Zacks Research Forecasts Lamb Weston's Q1 Earnings (NYSE:LW)

Cardano Risk Management B.V. Takes $232.16 Million Position in Lam Research Corporation $LRCX

Cardano Risk Management B.V. has acquired a significant new position in Lam Research Corporation, purchasing 535,748 shares valued at approximately $232.16 million, making it their 16th largest holding. Lam Research (NASDAQ:LRCX) recently reported strong quarterly results, exceeding revenue and EPS expectations, with revenue up …

Killam Apartment REIT Q2 Earnings Call Highlights

PensionDanmark Pensionsforsikringsaktieselskab Sells 12,119 Shares of Alnylam Pharmaceuticals, Inc. $ALNY

PensionDanmark Pensionsforsikringsaktieselskab reduced its stake in Alnylam Pharmaceuticals (NASDAQ:ALNY) by 35.1% in the second quarter, selling 12,119 shares and retaining 22,451 shares valued at $6.76 million. The stock opened at $219.20, significantly below its 52-week high, with institutional investors owning nearly 93% of the …

(CPZ) and the Role of Price-Sensitive Allocations

This article analyzes Calamos Long/short Equity & Dynamic Income Trust (NYSE: CPZ) using AI models to generate trading strategies. It highlights strong near and mid-term sentiment, weak long-term outlook, and compelling upside potential due to no remaining resistance levels above the current price. The …

Does Alamo Group’s (ALG) Buybacks and Bylaw Changes Reveal a Deeper Shift in Governance Priorities?

Alamo Group Inc. recently reported its Q2 2026 results, showing increased sales but slightly lower net income, alongside a completed share repurchase program. Concurrently, the company updated its bylaws to tighten shareholder proposal and director nomination procedures, formalize director compensation, and address conflicts of …

Is Alamos Gold (TSX:AGI) Undervalued After Its Production Guidance Cut?

Lamb Weston $LW Stock Position Increased by Sei Investments Co.

Sei Investments Co. significantly increased its stake in Lamb Weston by 128.6% in the first quarter, now owning 52,226 shares valued at $2.207 million. Several other institutional investors also adjusted their positions in the frozen potato product supplier. Lamb Weston recently reported strong quarterly …

Is Lam Research (LRCX) Fairly Valued On Record Results And New AI Guidance?

Alamar Biosciences (ALMR) Introduced Its NULISAseq Immune 340 Panel

Gradient Investments LLC Grows Stake in Lam Research Corporation $LRCX

Gradient Investments LLC increased its stake in Lam Research Corporation (LRCX) by 4.4% in the second quarter, bringing its total holdings to 150,167 shares valued at $65.1 million. This increase makes Lam Research the 25th largest holding in Gradient Investments' portfolio. The article also …

Lamar Advertising (LAMR) grows revenue and cash flow while managing $3.54B debt load

Lamar Advertising Company reported strong financial results for the first half of 2026, with net revenues reaching $1.14 billion and adjusted EBITDA at $529.7 million, primarily driven by billboard advertising. The company generated $399.8 million in operating cash flow and invested significantly in acquisitions …

Lamb Weston Holdings Inc. stock outperforms competitors on strong trading day

Lamb Weston Holdings Inc. (LW) stock increased by 1.16% to $52.27 on Friday, outperforming the broader market as both the S&P 500 Index and the Dow Jones Industrial Average also saw gains. The company's stock closed 22.07% below its 52-week high of $67.07. This …

Mangalam Cement Q1 Standalone Net Profit At 181M Rupees, Revenue Flat At 4.5B Rupees

Lamar Advertising (LAMR) Stock Stays Quiet As AFFO Outlook Improves

Lamar Advertising (LAMR) saw its stock remain relatively flat after announcing strong Q2 2026 earnings, with adjusted funds from operations (AFFO) per share at $2.40 and management raising full-year AFFO guidance. The company's digital revenue growth of 15.4% and programmatic sales increase of over …

Mangalam Cement net profit falls 44% YoY in Q1FY27 on margin squeeze